Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group (Q33502763)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group |
scientific article |
Statements
1 reference
Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group (English)
1 reference
K Furuse
1 reference
M Fukuoka
1 reference
Y Nishiwaki
1 reference
Y Kurita
1 reference
K Watanabe
1 reference
K Noda
1 reference
Y Ariyoshi
1 reference
T Tamura
1 reference
N Saijo
1 reference
1 reference
Identifiers
1 reference